指南与共识浆细胞疾病

国际骨髓瘤工作组孤立性浆细胞瘤诊疗推荐

International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.
指南 / 共识 · J Clin Oncol · 2026-07-22

孤立性浆细胞瘤是克隆性浆细胞的局部肿瘤,约50%在初始放疗后5年内进展为症状性骨髓瘤。诊断需全面排除多发性骨髓瘤,局部放疗仍是主要治疗,系统性治疗获益尚不明确。IMWG据此更新诊断、评估、治疗和疗效评估推荐。

要点

  • 诊断需用先进影像和敏感骨髓评估排除系统性骨髓瘤。
  • 局部放疗仍是孤立性浆细胞瘤的主要治疗手段。
  • 约50%患者初始放疗后5年内进展为症状性骨髓瘤。

核心结论

  • 孤立性浆细胞瘤诊断需全面排除需系统性治疗的多发性骨髓瘤。
  • 局部放疗仍是主要治疗,系统性治疗临床获益尚不明确。
  • IMWG更新了诊断、评估、治疗和疗效评估推荐。

研究设计与样本

  • 国际骨髓瘤工作组(IMWG)基于近期数据和诊断工具进展制定推荐。

主要发现

  • 约50%的孤立性浆细胞瘤在初始根治性局部放疗后5年内进展为症状性骨髓瘤。
  • 改进的诊断和监测工具提高了额外病灶和骨髓受累的检出敏感性。

关键数值与推荐

  • 骨髓浸润<10%克隆性浆细胞(免疫组化)且无系统性受累或骨髓瘤定义事件。

临床怎么用

  • 诊断时用先进影像、敏感骨髓评估及血尿检查全面排除多发性骨髓瘤。
  • 局部放疗作为主要治疗,系统性治疗需权衡尚不明确的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Solitary plasmacytomas (SPs) are rare localized tumors of clonal plasma cells, either in the bone (solitary bone plasmacytoma) or in soft tissue/extraosseous (extramedullary) with either no or with minimal bone marrow (BM) infiltration (<10% clonal plasma cells by immunohistochemistry) and no evidence of systemic involvement or myeloma defining events. Approximately 50% of SPs will progress to symptomatic myeloma within 5 years after initial definitive local radiotherapy. Increased availability of improved diagnostic and monitoring tools has increased the sensitivity of detection of additional lesions and marrow involvement and has implications for the follow-up strategy after treatment. Thus, the definitions and requirements for the diagnosis and follow-up of SPs are evolving. The diagnosis of SP requires the careful exclusion of multiple myeloma (MM) that would require systemic therapy, by using all the available methods to detect systemic disease (advanced imaging, sensitive BM assessment methods, blood and urine tests). Local radiotherapy remains the mainstay of therapy, and despite the availability of innovative drugs for MM, the clinical benefit of systemic therapy currently remains poorly defined. The International Myeloma Working Group provides here updated recommendations for the diagnosis, evaluation, treatment, and response assessment of patients with SPs, incorporating recent data and advances in diagnostic tools.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Kastritis E, Kumar SK, Rajkumar VS, et al. International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas. J Clin Oncol. 2026. PMID: 42485589. doi:10.1200/JCO-26-00410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。